FDA Drug Topics: Biosimilar and Interchangeable Products in the U.S.: Scientific Concepts, Clinical Use, and Practical Considerations – December 10, 2018
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Monday, December 10, 2018, at 1pm (EDT), CDER’s Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: Biosimilar and Interchangeable Products in the U.S.: Scientific Concepts, Clinical Use, and Practical Considerations. This webinar will provide an overview of biosimilar and interchangeable products and the approval process in the U.S. This webinar will also explain the various scientific concepts used in the development of biosimilar products and the FDA’s approval standards. In addition, we will describe some practical information regarding use of these products, such as labeling, terminology, and pharmacy substitution and review the resources available to health care professionals about biosimilar and interchangeable products.
For more information go to https://www.fda.gov/AboutFDA/WorkingatFDA/FellowshipInternshipGraduateFacultyPrograms/PharmacyStudentExperientialProgramCDER/ucm626386.htm